CompaniesClairvoyant Therapeutics

Clairvoyant Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

128

By Phase

PHASE2: 1

By Status

UNKNOWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2021

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT05646303Lead Sponsor

Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)

128 participants

Started: May 2, 2022 · Completed: Dec 31, 2024

Related Companies

Psyence

acquired